UNSPSC 51332864: Perphenazine enanthate

This classification denotes an antipsychotic agent with the molecular formula C28H38ClN3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z6RS3DKN8J, chemically known as 2-(4-(3-(2-chlorophenothiazin-10-yl)propyl)piperazin-1-yl)ethanol, heptanoate, but more generally known as perphenazine enanthate, which bears US NIH Compound Identifier 62871. European Medicines Agency schedules perphenazine enanthate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09736MIG.

Most nations, for tariff purposes, schedule perphenazine enanthate under HS 29343090. SMILES: CCCCCCC(=O)OCCN1CCN(CC1)CCCN2C3CCCCC3SC4C2CC(CC4)CL.

UNSPSC 51332864 Perphenazine enanthate is a Commodity code that nominally covers a specific antipsychotic pharmaceutical compound, but recent state and local solicitations tagged to this code diverge significantly from that narrow scope. The actual procurement activity under this code reflects state and local demand for pharmaceutical products and systems including emergency naloxone, safe drug deactivation equipment, generic multi-source pharmaceuticals, and over-the-counter products distributed through authorized wholesalers to government health facilities and community health programs. Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing consortiums (Minnesota Multistate Cooperative Purchasing Alliance, serving participating state and local government members across multiple states including Oregon).

Recent opportunities show activity concentrated in the South and Upper Midwest. Seminole County, Florida solicited an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; the procurement required electronic bidding through the county's e-Procurement Portal, E-Verify compliance, and carried a two-year initial term with one-year renewal option. Texas Health and Human Services Commission issued a Request for Information (HHS0017013, posted April 3, 2026) to gather vendor capabilities on direct-to-manufacturer prescription programs and therapeutic pharmacy initiatives serving self-insured health plans outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Department of Administration's Office of State Procurement issued an RFP through MMCAP (S1070000015802, due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson), with evaluation weighted 75 percent on price competitiveness and 25 percent on administrative compliance and capability factors; contracts were effective July 1, 2026.